DarioHealth Corp expected to post a loss of 33 cents a share - Earnings Preview

DarioHealth

07/03/2025 12:56

DarioHealth Corp DRIO.OQ DRIO.O is expected to show a rise in quarterly revenue when it reports  results on March 10 for the period ending December 31 2024

The New York City-based  company is expected to report a 104.3% increase in revenue to $7.387 million from $3.62 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for DarioHealth Corp is for a loss of 33 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for DarioHealth Corp is $3.50​, above​ its last closing price of $0.73. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.28
-0.27
-0.25
Beat
8.5
Jun. 30 2024
-0.55
-0.55
-0.08
Beat
85.6
Mar. 31 2024
-0.48
-0.40
-0.20
Beat
50.6​
Dec. 31 2023
-0.54
-0.55
-0.50
Beat
9.6
​​Sep. 30 2023
-0.48
-0.46
-0.49
Missed
-6.5
Jun. 30 2023
-0.57
-0.52
-0.58
Missed
-11.1​
Mar. 31 2023
-0.49
-0.50
-0.45
Beat
9.6
Dec. 31 2022
-0.56
-0.65
-0.51
Beat
21.8

This summary was machine generated March 7 at 12:56 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)